Quantcast

Latest Antiemetics Stories

2014-10-24 08:26:17

Sannabis is producing a "Made in Colombia" topical cannabis medical product for worldwide distribution through infomercials. BOGOTA, Colombia, Oct. 24, 2014 /PRNewswire/ -- New Colombia Resources, Inc. (OTCQB: NEWC) ("New Colombia or the Company"), a U.S. company with coal and other resource assets in Colombia, is pleased to announce their Colombian subsidiary, Sannabis S.A.S., has legally produced a trial run of cannabis based products on an Indian reservation. The Sannabis brand...

2014-10-23 08:37:02

LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 mug/kg, Palonosetron, administered as a singledose, is as effective as ondansetron 0.15 mg/kg given three times a day to a maximum dose of 32mg ~ No safety concerns were raised by the study Helsinn Group, the company focused on building quality cancer care, presented data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 mug/kg, is a...

2014-10-21 16:28:08

MIAMI, Oct. 21, 2014 /PRNewswire/ -- As Floridians get set to hit the polls on Nov. 4 and decide the fate of legalizing medical marijuana in this state, another debate is brewing: do the benefits of medical marijuana to treat chronic pain outweigh the risks? According to a recent survey conducted online in October by Harris Poll on behalf of Miami Jewish Health Systems among over 2,000 adults, two out of three Americans - some 68% - believe that yes, the benefits of using medical...

2014-10-21 08:35:43

Subsidiary Adds Medical Director to Board of Directors HOUSTON, Oct. 21, 2014 /PRNewswire/ -- Solanbridge Group Inc (OTC: SLNX) is pleased to announce that its subsidiary Solanbridge Group Nova Scotia, Inc., has added Ms. Wendy Coffin to its Board of Directors. She will act as the subsidiary's Medical Director. Ms. Coffin joined the Board on October 1, 2014. She will provide Solanbridge with invaluable medical and pharmaceutical experience. Charles R. Shirley, CEO of...

2014-10-20 20:25:49

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsTreatments for nausea and vomiting - explore business trends, R&D, and revenue forecastsWhat's the future of treating nausea and vomiting? For those medicines you get sales predictions, also exploring research and development. Those treatments hold high potential. There you assess results, progress, therapies, and opportunities.Visiongain's new report forecasts those revenues to 2024 at overall world market, submarket, product,...

2014-10-20 08:30:12

DENVER, Oct. 20, 2014 /PRNewswire/ -- AmeriCann, Inc. (ACAN OTCQX), a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois. "AmeriCann's management team members have had extensive first-hand experience with compassionate medical marijuana programs for many years," AmeriCann CEO Tim Keogh stated. "We have seen the tremendous benefits that patients have...

2014-10-17 16:24:19

Popular alcohol delivery app expands market reach to bring medicinal marijuana to Los Angeles patients in need LOS ANGELES, Oct. 17, 2014 /PRNewswire/ -- Introducing the country's first in-app, on-demand medical marijuana delivery service for both iOS and Android, Nestdrop. Available today for alcohol deliveries for Los Angeles area residents, Nestdrop's medical marijuana delivery service will launch soon in the same easy-to-use app and promises delivery in under an hour. Unlike...

2014-10-16 08:32:00

AUSTIN, Texas, Oct. 16, 2014 /PRNewswire/ -- A quadriplegic battling muscle spasms has created the EpiVape - a disposable CBD hemp oil vaporizer that safely and easily delivers small doses of 100% legal hemp extract proven to significantly reduce or alleviate seizures and spasms related to neurological disorders such as epilepsy, Parkinson's, MS, spinal cord injuries. Photo - http://photos.prnewswire.com/prnh/20141015/152481 Logo -...

2014-10-15 08:30:29

RADNOR, Pa., Oct. 15, 2014 /PRNewswire/ -- Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal cannabinoid treatments, today announced the successful closing of $13 million in funding. New investors in Zynerba include one of the top-seven life sciences public investors, Perceptive Advisors LLC. Proceeds of the fundraising will be used for development efforts for the first and only transdermal cannabinoid therapies as...

2014-10-13 08:26:31

-- First New Fixed Combination Targeting Two Critical Pathways Involved in CINV -- LUGANO, Switzerland and WOODCLIFF LAKE, N.J., Oct. 13, 2014 /PRNewswire/ -- Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO(®) for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. AKYNZEO is the first approved fixed...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related